Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Notice of Title Change for NOT-HL-16-314 to "Notice of Intent to Publish a
Funding Opportunity Announcement for the Blood and Marrow Transplant
Clinical Trials Network Data Coordinating Center (U24)"
(NOT-HL-16-218)
National Heart, Lung, and Blood Institute
Funding Opportunity Announcement for the Blood and Marrow Transplant
Clinical Trials Network Data Coordinating Center (U24)"
(NOT-HL-16-218)
National Heart, Lung, and Blood Institute
Notice of Change and Informational Webinar for RFA-HL-16-009 "NHLBI SBIR
Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies
for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)"
(NOT-HL-16-317)
National Heart, Lung, and Blood Institute
Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies
for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44)"
(NOT-HL-16-317)
National Heart, Lung, and Blood Institute
NHLBI TOPMed Program: Integrative Omics Approaches for Analysis of
TOPMed Data (U01)
(RFA-HL-17-011)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): July 6, 2016, by 5:00 PM local time of applicant
organization. All types of non-AIDS applications allowed for this funding
opportunity announcement are due on this date.
TOPMed Data (U01)
(RFA-HL-17-011)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): July 6, 2016, by 5:00 PM local time of applicant
organization. All types of non-AIDS applications allowed for this funding
opportunity announcement are due on this date.
Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung,
Blood, and Sleep Technologies with Small Commercial Markets (R44)
(RFA-HL-17-012)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 20, 2016; June 19, 2017; June 20, 2018, by
5:00 PM local time of applicant organization.
Blood, and Sleep Technologies with Small Commercial Markets (R44)
(RFA-HL-17-012)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
Application Receipt Date(s): June 20, 2016; June 19, 2017; June 20, 2018, by
5:00 PM local time of applicant organization.
Mentored Quantitative Research Development Award (Parent K25)
(PA-16-194)
National Institutes of Health
National Heart, Lung, and Blood Institute
(PA-16-194)
National Institutes of Health
National Heart, Lung, and Blood Institute
Academic Research Enhancement Award (Parent R15)
(PA-16-200)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
(PA-16-200)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
Midcareer Investigator Award in Patient-Oriented Research (Parent K24)
(PA-16-206)
National Institutes of Health
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
(PA-16-206)
National Institutes of Health
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
Lasker Clinical Research Scholars Program (Si2/R00)
(PAR-16-203)
National Institutes of Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
(PAR-16-203)
National Institutes of Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
No hay comentarios:
Publicar un comentario